Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy

• Jen-Yi Lee,

  Affiliations Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Yee-Ming Lee,

  Affiliations Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Gee-Chen Chang,

  Affiliations Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, Institute of Biomedical Science, College of Life Sciences, National Chung-Hsing University, Taichung, Taiwan

  ⨯
• Sung-Liang Yu,

  Affiliation Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Wan-Yu Hsieh,

  Affiliations Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Jeremy J. W. Chen,

  Affiliation Institute of Biomedical Science, College of Life Sciences, National Chung-Hsing University, Taichung, Taiwan

  ⨯
• Huei-Wen Chen ,

  * E-mail: shwchen@ntu.edu.tw

  Affiliation Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Pan-Chyr Yang

  Affiliation Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan

  ⨯